Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease
Clinical trial NCT02499783 · COMPLETED
Trial details
- NCT number
- NCT02499783
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-17
- Primary completion
- 2017-05-19
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.